- Claire obtained her PhD in Hemato-Oncology in 2017 from Institut Curie/Université Paris Diderot for her work on a signalling pathway involved in T cell leukaemia.
- She holds a postgraduate degree in Biopharmaceutical Management from ESCP Business School and obtained her MSc degree from the French Engineering School Agrocampus Ouest in 2013.
- Claire joined Andera Partners in 2018.
- She speaks French and English.
Investments of Claire
Small molecule for the treatment of pharmacoresistant partial epilepsy
Small molecules to increase tumor detection by the immune system
Neuromodulation technology for the treatment of incontinence
Inhaled anti-fibrotic drug for the treatment of orphan respiratory disease